PharmaCielo (TSE:PCLO) has released an update.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
PharmaCielo, a leading cultivator and producer of cannabis extracts, has announced an anticipated reinstatement for trading on the TSX Venture Exchange following a successful resolution of previous regulatory issues. The company has also been progressing with its efficiency program, reducing its monthly cash burn rate, and is finalizing a private placement to boost its finances. Additionally, PharmaCielo is extending its international footprint with an impending acquisition of Siam Ventures Corporation in Thailand.
For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.